Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples